It provides actionable evidence that if the goal is durable neural remodeling and mTOR suppression, continuous intranasal administration is vastly superior to sporadic systemic injections
Our data shows substantial shifts in the use of GLP-1 medicines, with total sales jumping from 58,000 in May 2020 to 500,000 in April 2025, said lead author Associate Professor Michael Falster, Medicines Intelligence Research Program at UNSW Medicine & Health
"For women with obesity, hormonal changes during menopause can drive weight gain and increase the risk of a heart attack," said Mette Thomsen, group vice president and head of Global Medical Affairs at Novo Nordisk
Clinical trials such as the STEP programme have examined body composition changes with treatment
Is Compounded GLP-1 the Same as Ozempic or Wegovy